|
|
Volumn 20, Issue 1, 2002, Pages 24-28
|
|
Experience with methotrexate, 5-fluorouracil, and leucovorin (MFL): A first line effective, minimally toxic regimen for metastatic breast cancer
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
TAMOXIFEN;
ADJUVANT THERAPY;
ADULT;
AGED;
ANEMIA;
ARTICLE;
BONE METASTASIS;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CYTOPENIA;
DISEASE COURSE;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
LEUKOPENIA;
LIVER METASTASIS;
LIVER TOXICITY;
LUNG METASTASIS;
METASTASIS;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
BRAIN NEOPLASMS;
BREAST NEOPLASMS;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
MIDDLE AGED;
MITOXANTRONE;
PROSPECTIVE STUDIES;
|
|
EID: 0036171774
PISSN: 07357907
EISSN: None
Source Type: Journal
DOI: 10.1081/CNV-120000362 Document Type: Article |
|
Times cited : (1)
|
|
References (11)
|
